ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 752703 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 752703; 2) Community: the network communities that were significantly associated with the response to NSC 752703; 3) Molecule: the relationships between components within communities and NSC 752703; 4) MDR: the compounds that were significantly associated with the NSC 752703.

NSC Compound Enrichment Correlation
NSC 623176 Null 0.0100995289754788 0.32339159
NSC 627168 2-[(3-N',N'-Dimethylamino)propyl]-9-methoxy-5-nitro-[6H]- pyrazolo[3,4,5-kl]acridine, free base 0.0100995289754788 0.27143276
NSC 639174 Camptothecin Derivative 0.0100995289754788 0.40129309
NSC 639186 Raltitrexed 0.0100995289754788 0.46315175
NSC 658368 Null 0.0100995289754788 0.24624664
NSC 671009 2H-Thieno[3',4':4,5]cyclopent[1,2-d]oxazole- 2,7(7aH)-dione,4,6-dibromo-3,3a-dihydro- 0.0100995289754788 0.35102694
NSC 673452 Null 0.0100995289754788 0.35825004
NSC 676917 1-[m-Anisidic anilino malonyl]-3-methyl-4-[4'-.beta.-sulphato ethyl sulphonyl phenyl azo]-5-pyrazolone 0.0100995289754788 0.42673929
NSC 679287 Null 0.0100995289754788 0.28401847
NSC 681635 Camptothecin Derivative 0.0100995289754788 0.45164066
Total:90  Current:21    [First] [Prev] [Next] [Last]